Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Agne Taraseviciute

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Current Opinion in Pediatrics|December 27, 2018
Advances in hematopoietic cell transplant for the treatment of hematologic malignanciesAgne Taraseviciute, Michael A Pulsipher
European Journal of Medical Research|May 26, 2006
Severe pulmonary hypertension in postmenopausal obese womenAgne Taraseviciute, Norbert F Voelkel
CNS Drugs|November 3, 2018
Neurotoxicity Associated with CD19-Targeted CAR-T Cell TherapiesJuliane Gust, Agne Taraseviciute, Cameron J Turtle
The American Journal of Pathology|January 1, 2010
Quantitative analysis of three-dimensional human mammary epithelial tissue architecture reveals a role for tenascin-C in regulating c-met functionAgne Taraseviciute, Benjamin T Vincent, Pepper Schedin, et al.
Journal of Pediatric Hematology/Oncology|April 12, 2019
What is the Role of Hematopoietic Cell Transplantation (HCT) for Pediatric Acute Lymphoblastic Leukemia (ALL) in the Age of Chimeric Antigen Receptor T-Cell (CART) Therapy?Agne Taraseviciute, Larisa Broglie, Rachel Phelan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 14, 2018
Manufacture of Chimeric Antigen Receptor T Cells from Mobilized Cyropreserved Peripheral Blood Stem Cell Units Depends on Monocyte DepletionAnnette Künkele, Christopher Brown, Adam Beebe, et al.
Blood Advances|January 25, 2018
Poor outcome with hematopoietic stem cell transplantation for bone marrow failure and MDS with severe MIRAGE syndrome phenotypeJay Sarthy, Ji Zha, Daria Babushok, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2016
Preclinical Assessment of CD171-Directed CAR T-cell Adoptive Therapy for Childhood Neuroblastoma: CE7 Epitope Target Safety and Product Manufacturing FeasibilityAnnette Künkele, Agne Taraseviciute, Laura S Finn, et al.
Blood|November 8, 2019
Preemptive mitigation of CD19 CAR T-cell cytokine release syndrome without attenuation of antileukemic efficacyRebecca A Gardner, Francesco Ceppi, Julie Rivers, et al.
Pediatric Blood & Cancer|April 1, 2018
Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trialNavin Pinto, Steven G DuBois, Araz Marachelian, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Current Opinion in Pediatrics|December 27, 2018
Advances in hematopoietic cell transplant for the treatment of hematologic malignanciesAgne Taraseviciute, Michael A Pulsipher
European Journal of Medical Research|May 26, 2006
Severe pulmonary hypertension in postmenopausal obese womenAgne Taraseviciute, Norbert F Voelkel
CNS Drugs|November 3, 2018
Neurotoxicity Associated with CD19-Targeted CAR-T Cell TherapiesJuliane Gust, Agne Taraseviciute, Cameron J Turtle
The American Journal of Pathology|January 1, 2010
Quantitative analysis of three-dimensional human mammary epithelial tissue architecture reveals a role for tenascin-C in regulating c-met functionAgne Taraseviciute, Benjamin T Vincent, Pepper Schedin, et al.
Journal of Pediatric Hematology/Oncology|April 12, 2019
What is the Role of Hematopoietic Cell Transplantation (HCT) for Pediatric Acute Lymphoblastic Leukemia (ALL) in the Age of Chimeric Antigen Receptor T-Cell (CART) Therapy?Agne Taraseviciute, Larisa Broglie, Rachel Phelan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 14, 2018
Manufacture of Chimeric Antigen Receptor T Cells from Mobilized Cyropreserved Peripheral Blood Stem Cell Units Depends on Monocyte DepletionAnnette Künkele, Christopher Brown, Adam Beebe, et al.
Blood Advances|January 25, 2018
Poor outcome with hematopoietic stem cell transplantation for bone marrow failure and MDS with severe MIRAGE syndrome phenotypeJay Sarthy, Ji Zha, Daria Babushok, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2016
Preclinical Assessment of CD171-Directed CAR T-cell Adoptive Therapy for Childhood Neuroblastoma: CE7 Epitope Target Safety and Product Manufacturing FeasibilityAnnette Künkele, Agne Taraseviciute, Laura S Finn, et al.
Blood|November 8, 2019
Preemptive mitigation of CD19 CAR T-cell cytokine release syndrome without attenuation of antileukemic efficacyRebecca A Gardner, Francesco Ceppi, Julie Rivers, et al.
Pediatric Blood & Cancer|April 1, 2018
Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trialNavin Pinto, Steven G DuBois, Araz Marachelian, et al.
Pageof 3